Bortezomib in Treating Patients With Myelodysplastic Syndromes

NCT00262873 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
8
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Rochester